Reviva Pharmaceuticals Holdings, Inc.
General ticker "RVPH" information:
- Sector: Health Care
- Industry: Pharmaceuticals
- Capitalization: $34.4M (TTM average)
Reviva Pharmaceuticals Holdings, Inc. does not follow the US Stock Market performance with the rate: -13.5%.
Estimated limits based on current volatility of 4.5%: low 0.57$, high 0.62$
Factors to consider:
- Total employees count: 15 (+50.0%) as of 2023
- Company does not operate outside North America (retrieved using AI)
- Top business risk factors: Dependence on single product candidate, Operational and conduct risks, Pandemic risks, Liquidity and credit risks, Strategic risks and growth management
- Current price 29.5% below estimated low
- Earnings for 9 months up through Q3 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [0.84$, 2.58$]
- 2025-12-31 to 2026-12-31 estimated range: [0.92$, 2.75$]
Financial Metrics affecting the RVPH estimates:
- Positive: with PPE of -1.8 at the end of fiscal year the price was low
- Negative: negative Operating income
- Negative: Operating cash flow per share per price, % of -60.80 <= 0.33
- Positive: Interest expense per share per price, % of 0.03 <= 0.79
- Positive: Inventory ratio change, % of 0 <= 0
- Negative: negative Industry operating cash flow (median)
Short-term RVPH quotes
Long-term RVPH plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $0.00MM | $0.00MM | $0.00MM |
| Operating Expenses | $24.31MM | $39.50MM | $30.80MM |
| Operating Income | $-24.31MM | $-39.50MM | $-30.80MM |
| Non-Operating Income | $-0.01MM | $0.26MM | $0.90MM |
| Interest Expense | $0.00MM | $0.00MM | $0.02MM |
| R&D Expense | $18.95MM | $31.42MM | $22.91MM |
| Income(Loss) | $-24.32MM | $-39.24MM | $-29.90MM |
| Taxes | $0.02MM | $0.02MM | $0.02MM |
| Profit(Loss)* | $-24.34MM | $-39.26MM | $-29.92MM |
| Stockholders Equity | $8.39MM | $5.72MM | $0.81MM |
| Assets | $18.92MM | $23.70MM | $15.50MM |
| Operating Cash Flow | $-18.96MM | $-28.32MM | $-33.54MM |
| Financing Cash Flow | $7.79MM | $33.17MM | $23.65MM |
| Earnings Per Share** | $-1.25 | $-1.65 | $-0.90 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.